Monday’s IBD 50 Growth Stocks To Watch pick, biotech leader Arcutis Biotherapeutics (ARQT), is breaking out past two buy points. That makes Arcutis stock one of the best stocks to watch right now. Arcutis Biotherapeutics develops dermatology treatments for unmet needs of immune-related skin diseases and conditions. Its main products approved by the U.S. Food and Drug Administration are Zoryve…
New data the Agriculture Department released Friday created serious doubts about whether China will really buy millions of bushels of...
A few months ago, The Conference Board reported the finding that the sheer number of workers aged 55 or older...
The Japanese investment giant is no longer a party in interest in the Israeli digital insurance company. ...
Indian equities closed the week on a firmer note Friday, with technology and pharmaceutical shares leading modest gains as investors...
Days before President Donald Trump was sworn in for his second term, he acknowledged the high prices Americans were seeing...
GDP growth recovered strongly in the third quarter of 2025, after the economy contracted during the second quarter due to...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
